BAM Stock Analysis: Brookfield Asset Management | NYSE
Asset Management | NYSE, USA | Market Cap: 82.339m USD | 12M Return: 7.1% | CA1130041058 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 136M
EPS Trend: 99.2%
Qual. Beats: 1
Rev. Trend: 87.0%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 5.7 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Brookfield Asset Management Ulc is a private equity and alternative asset management firm that focuses on acquisitions and growth capital investments across real asset categories, including real estate, infrastructure, renewable power, private equity, and credit. The firm serves a broad institutional client base, such as pension plans, sovereign wealth funds, endowments, foundations, financial institutions, and high net worth individuals, through public and private funds, listed partnerships, separate accounts, and co-investments. Founded in 2022 and headquartered in New York, the firm operates as a subsidiary of Brookfield Corporation and uses fundamental and operational analysis, supported by both in-house and external research, to guide its investment decisions.
As an asset manager, the firm typically generates revenue through management fees charged on assets under management, along with performance-based fees tied to investment returns, which is the standard economic model across the asset management industry. Brookfields emphasis on real assets distinguishes it within the broader Financials sector, as these long-duration, often inflation-linked categories (such as infrastructure and renewable power) appeal to institutional investors seeking stable, long-term cash flows.
- Fee-bearing capital growth accelerates fee-related earnings
- Real assets and infrastructure fundraising boost AUM
- Private credit and insurance partnerships expand revenue streams
| Net Income: 4.72b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.11 > 1.0 |
| NWC/Revenue: -0.70% < 20% (prev 80.82%; Δ -81.52% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.99b > Net Income 4.72b |
| Net Debt (5.83b) to EBITDA (6.37b): 0.92 < 3 |
| Current Ratio: 0.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.61b) vs 12m ago -1.99% < -2% |
| Gross Margin: 87.85% > 18% (prev 69.87%; Δ 17.98% > 0.5%) |
| Asset Turnover: 29.20% > 50% (prev 26.48%; Δ 2.72% > 0%) |
| Interest Coverage Ratio: 21.46 > 6 (EBIT TTM 6.27b / Interest Expense TTM 292.3m) |
| A: -0.00 (Total Current Assets 5.07b - Total Current Liabilities 5.11b) / Total Assets 27.4b |
| B: 0.03 (Retained Earnings 884.0m / Total Assets 27.4b) |
| C: 0.29 (EBIT TTM 6.27b / Avg Total Assets 22.0b) |
| D: 0.74 (Book Value of Equity 9.43b / Total Liabilities 12.7b) |
| Altman-Z'' = 2.79 = A |
| DSRI: 0.55 (Receivables 4.38b/5.46b, Revenue 6.41b/4.37b) |
| GMI: 0.80 (GM 69.87% / 87.85%) |
| AQI: 1.35 (AQ_t 0.81 / AQ_t-1 0.60) |
| SGI: 1.47 (Revenue 6.41b / 4.37b) |
| TATA: 0.10 (NI 4.72b - CFO 1.99b) / TA 27.4b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of November 17, 2026, the stock is trading at USD 50.89 with a total of 2,485,066 shares traded. Over the past week, the price has changed by -6.07%, over one month by +12.29%, over three months by -2.25% and over the past year by +7.07%.
Current recommended Stop Loss: 48.50 (which is 4.7% or 1.5 ATR below the current price).
Brookfield Asset Management has received a consensus analysts rating of 3.79. Therefore, it is recommended to hold BAM.
- StrongBuy: 7
- Buy: 3
- Hold: 8
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 56.7 | 11.3% |
P/E Trailing = 17.4678
P/E Forward = 24.57
P/S = 12.4116
P/B = 8.7149
P/EG = 0.9301
Revenue TTM = 6.41b USD
EBIT TTM = 6.27b USD
EBITDA TTM = 6.37b USD
Long Term Debt = 5.01b USD (from longTermDebt, last quarter)
Short Term Debt = 252.0m USD (from shortTermDebt, last quarter)
Debt = 6.49b USD (from shortLongTermDebtTotal, last quarter) + Leases 252.0m
Net Debt = 5.83b USD (calculated: Debt 6.49b - CCE 657.0m)
Enterprise Value = 88.2b USD (82.3b + Debt 6.49b - CCE 657.0m)
Interest Coverage Ratio = 21.46 (Ebit TTM 6.27b / Interest Expense TTM 292.3m)
EV/FCF = 44.27x (Enterprise Value 88.2b / FCF TTM 1.99b)
FCF Yield = 2.26% (FCF TTM 1.99b / Enterprise Value 88.2b)
FCF Margin = 31.06% (FCF TTM 1.99b / Revenue TTM 6.41b)
Net Margin = 73.56% (Net Income TTM 4.72b / Revenue TTM 6.41b)
Gross Margin = 87.85% ((Revenue TTM 6.41b - Cost of Revenue TTM 779.4m) / Revenue TTM)
Gross Margin QoQ = none% (prev 92.53%)
Tobins Q-Ratio = 3.22 (Enterprise Value 88.2b / Total Assets 27.4b)
Interest Expense / Debt = 4.50% (Interest Expense 292.3m / Debt 6.49b)
Taxrate = 14.37% (900.5m / 6.26b)
NOPAT = 5.37b (EBIT 6.27b * (1 - 14.37%))
Current Ratio = 0.99 (Total Current Assets 5.07b / Total Current Liabilities 5.11b)
Debt / Equity = 0.69 (Debt 6.49b / totalStockholderEquity, last quarter 9.43b)
Debt / EBITDA = 0.92 (Net Debt 5.83b / EBITDA 6.37b)
Debt / FCF = 2.93 (Net Debt 5.83b / FCF TTM 1.99b)
Total Stockholder Equity = 8.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 21.48% (Net Income 4.72b / Total Assets 27.4b)
RoE = 57.80% (Net Income TTM 4.72b / Total Stockholder Equity 8.16b)
RoCE = 47.62% (EBIT 6.27b / Capital Employed (Equity 8.16b + L.T.Debt 5.01b))
RoIC = 24.16% (NOPAT 5.37b / Invested Capital 22.2b)
WACC = 9.99% (E(82.3b)/V(88.8b) * Re(10.47%) + D(6.49b)/V(88.8b) * Rd(4.50%) * (1-Tc(0.14)))
Discount Rate = 10.47% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 14.40 | Cagr: 0.06%
[DCF] Terminal Value 72.86% ; FCFF base≈1.47b ; Y1≈1.68b ; Y5≈2.48b
[DCF] Fair Price = 14.46 (EV 28.9b - Net Debt 5.83b = Equity 23.1b / Shares 1.60b; r=9.99% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.22 | EPS CAGR: 11.19% | SUE: 1.62 | # QB: 1
Revenue Correlation: 86.99 | Revenue CAGR: 15.75% | SUE: 1.71 | # QB: 1
EPS current Quarter (2027-03-31): EPS=0.51 | Chg30d=-0.98% | Revisions=-50% | Analysts=12
EPS current Year (2026-12-31): EPS=1.84 | Chg30d=+0.38% | Revisions=-70% | GrowthEPS=+11.4% | GrowthRev=+31.9%
EPS next Year (2027-12-31): EPS=2.16 | Chg30d=-0.31% | Revisions=-50% | GrowthEPS=+17.4% | GrowthRev=+14.2%
[Analyst] Revisions Ratio: -75% (up=1, down=16)